0001171843-19-000065.txt : 20190103
0001171843-19-000065.hdr.sgml : 20190103
20190103081959
ACCESSION NUMBER: 0001171843-19-000065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kowalsky Matthew Paul
CENTRAL INDEX KEY: 0001705824
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 19503680
MAIL ADDRESS:
STREET 1: 28 SEVINOR RD
CITY: MARBLEHEAD
STATE: MA
ZIP: 01945
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-0102
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
ownership.xml
X0306
4
2018-12-31
0
0001359931
PROTEON THERAPEUTICS INC
PRTO
0001705824
Kowalsky Matthew Paul
C/O PROTEON THERAPEUTICS, INC.
200 WEST STREET
WALTHAM
MA
02451
0
1
0
0
VP, Legal and Secretary
Common Stock
2018-12-31
5
A
0
E
2448
1.93
A
29479
D
The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ George A. Eldridge, attorney-in-fact
2019-01-03